Novel SDHD gene mutation (H102R) in a patient with metastatic cervical paraganglioma effectively treated by peptide receptor radionuclide therapy

Poeppel, Thorsten D; Yuece, Ali; Boy, Christian; Metz, Klaus A; Kaminsky, Elke; Neumann, Hartmut P; Rosenbaum, Sandra J; Mann, Klaus; Moeller, Lars C (2011). Novel SDHD gene mutation (H102R) in a patient with metastatic cervical paraganglioma effectively treated by peptide receptor radionuclide therapy. Journal of clinical oncology, 29(33), e812-5. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2011.36.2269

Full text not available from this repository. (Request a copy)

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Clinic of Nuclear Medicine

UniBE Contributor:

Boy, Christian

ISSN:

0732-183X

Publisher:

American Society of Clinical Oncology

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:19

Last Modified:

17 Mar 2015 19:25

Publisher DOI:

10.1200/JCO.2011.36.2269

PubMed ID:

22025150

Web of Science ID:

000297257400005

URI:

https://boris.unibe.ch/id/eprint/6163 (FactScience: 211065)

Actions (login required)

Edit item Edit item
Provide Feedback